TITAN PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
공식 등기 데이터
0팔로워
2015설립
TITAN PHARMACEUTICALS INC 소개
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. In the same month, it also posted approximately $1.7 million in revenue, in large part drawn from its licensing for its European intellectual property rights for Probuphine to the Italian pharmaceutical company Molteni – a leading European opioid manufacturer and also a subsidiary of the German Pharmaceutical juggernaut Merck Group.
Source: Wikipedia
산업Biological Products, (No Diagnostic Substances)
본사400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
설립2015
법적 형태C Corporation
상태운영 중
특허특허 6건
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCESJP2025069303A · 2025
LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTSJP2024133539A · 2024
주요 수치
법적 정보
| 법인명 | TITAN PHARMACEUTICALS INC |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 910267SEC EDGAR에서 보기 ↗ |
| EIN | 94-3171940 |
| 업종 코드(SIC) | 2836 |
| 등기 주소 | 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청